Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Constriction, Pathological

5,7-dihydroxytryptamine has been researched along with Constriction, Pathological in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, S; Furukawa, Y; Ishikawa, K; Ishikawa, T; Iwanaga, Y; Nakano, M; Okuyama, S; Suenaga, H; Yamagata, H; Yasuda, S; Yoshida, M1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Constriction, Pathological

ArticleYear
Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
    Cellular and molecular neurobiology, 2014, Volume: 34, Issue:8

    Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Pain; Constriction, Pathologic; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Emotions; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gyrus Cinguli; Imipramine; Male; Phosphorylation; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Serotonin; Spinal Cord

2014